We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Bacterial Isolates Identified by Colorimetric Cards

By LabMedica International staff writers
Posted on 21 Dec 2010
A rapid and accurate bacterial identification system for Staphylococci species has been validated in a clinical setting. More...


A procedure that uses colorimetric identification card and automation has been compared with molecular methods to identify bacteria from patient's samples that were isolated and recovered during routine testing.

Scientists from the Medical School at the University of Athens (Greece), isolated 147 clinical isolates: 52 Staphylococcus aureus, 50 Staphylococcus epidermidis, and 45 other coagulase-negative Staphylococci (CoNS). These isolates were recovered from various clinical samples including blood, wound, catheter tips, respiratory, and urine during routine testing, and for the majority of them, their isolation was considered clinically significant. The bacteria were first identified by molecular methodology and then comparatively tested by Vitek 2, colorimetric identification card, and Phoenix using the novel 0.25 McFarland and the standard 0.50 McFarland inoculum protocols.

All S. aureus isolates were accurately identified. Vitek 2 (bioMérieux, Marcy l'Etoile, France) identified correctly all S. epidermidis and 93.3% of the other CoNS, whereas the respective rates were 86% and 82.2% for Phoenix's standard and 92% and 82.2% for the novel protocol. The PMIC/ID-53 panel for Gram-positive cocci and software version V5.10A/V4.23D were used for identification by Phoenix system (Becton Dickinson Diagnostic Systems, Franklin Lane, NJ, USA).

The authors concluded that both systems provide excellent identification of S. aureus, but Vitek 2 recognizes CoNS species more accurately than Phoenix. The 0.25 McFarland protocol does not improve system performance. However, they also note specificity of testing is an important parameter and needs to be determined also. It is imperative that such evaluation studies use reference phenotypic or molecular identification methods for comparison. The study was published online on November 19, 2010 in Diagnostic Microbiology and Infectious Disease.

Related Links:
University of Athens
bioMérieux
Becton Dickinson Diagnostic Systems



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.